Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sulodexide for adverse effects after varicose vein treatment
NCT05654233Unknown
- Sponsor
- Chengdu University of Traditional Chinese Medicine
- Start
- Feb 2023
- Primary completion
- Aug 2023
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of sulodexide in Varicose Veins (2 arms), sponsored by Chengdu University of Traditional Chinese Medicine. Primary endpoints: Changes in pigmentation area and color depth at 3 months, Changes in the incidence and hardness of fibrous induration at 3 months and 1 more. Status: unknown.
02
Drugs
sulodexide
03
Conditions
Varicose Veins
Beyond the preview
Go deeper on NCT05654233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05654233.